首页 | 本学科首页   官方微博 | 高级检索  
检索        

消疹散联合吉非替尼治疗肺腺癌临床研究
引用本文:张培影,裴俊文.消疹散联合吉非替尼治疗肺腺癌临床研究[J].河南中医药学刊,2010(1):21-21,23.
作者姓名:张培影  裴俊文
作者单位:[1]南京中医药大学第一临床医学院,江苏南京210029 [2]徐州市中心医院,江苏徐州221009 [3]河南省肿瘤医院,河南郑州450008
摘    要:目的:验证消疹散在治疗肺腺癌中降低吉非替尼副作用的临床效果。方法:将60例放化疗失败的肺腺癌病人分为消疹散加吉非替尼组与单纯吉非替尼组比较治疗效果。结果:各级比较两组皮疹发生率差异有显著意义,两组疗效比较差异无显著意义。结论:中药消疹散可以有效降低吉非替尼引起的皮疹反应,但没有降低其治疗作用。

关 键 词:消疹散  吉非替尼  肺腺癌

The Clinical Research of The Powder for Removing Rashes United Gefitinib on Adenocarcinoma of Lung
Zhang Peiying,Pei Junwen.The Clinical Research of The Powder for Removing Rashes United Gefitinib on Adenocarcinoma of Lung[J].Journal of Henan college of Traditional Chinese Medicine,2010(1):21-21,23.
Authors:Zhang Peiying  Pei Junwen
Institution:1.NO.1 Clinical Medical College,Nanjing University of Chinese Medicine,Nanjing,Jiangsu,China 2100292. Xuzhou Municipal Central Hospital,Xuzhou,Jiangsu,China 221000Henan3. Province Hospital of Tumor,Zhengzhou,Henan,China 450008)
Abstract:Objective:to check the clinical effect of the powder for removing rashes to degrade the side effect of gefitinib in treating adenocarcinoma of lung.Methods:60 cases of patients suffering adenocarcinoma of lung after radiotherapy and chemotherapy failure were divided into the powder for removing rashes united Gefitinib group and Gefitinib group.Results:the incidence rate of erythra and the clinical effect had the significance difference in two groups.Conclusion:the powder for removing rashes could cut down the rashes reaction induced by Gefitinib but could not degrade its therapeutic action.
Keywords:the powder for removing rashes  Gefitinib  adenocarcinoma of lung
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号